Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women’s Health Initiative hormone therapy trials

By sjmartinez • July 14, 2022

Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, Crandall CJ, Cauley JA, LeBoff MS, McCloskey EV, Kanis JA. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials. Osteoporos Int. 2022 Jul 14. doi: 10.1007/s00198-022-06483-y. Epub ahead of print. PMID: 35833956.

Tags: Epidemiology, Falls, Fracture risk, FRAX, Infectious Diseases, Menopausal hormone therapy, Osteoporosis, Postmenopausal women, Publications

Atomically Precise Polyanionic Boron Cluster Agents with Broad-Spectrum Antiviral Activity

Wang Y, Arumugam B, Doud E, DeLuca D, Rebelo M, Yang OO, Spokoyny AM. Atomically Precise Polyanionic Boron Cluster Agents with Broad-Spectrum Antiviral Activity. Precis[...]

Don’t Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for Treatment and Prevention of HIV

Lee TH, Bhattacharya D, Kim HN. Don't Drop the B: Risk of Hepatitis B Virus Infection and Reactivation in the Era of Tenofovir-Sparing Regimens for[...]

Clinical and genomic characteristics of hypervirulent Klebsiella pneumoniae isolated from throat culture suggesting an emerging causative agent of pharyngitis

Whitehill GD, Gonzalez-Ferrer S, Tsan AT, Yang S. Clinical and genomic characteristics of hypervirulent Klebsiella pneumoniae isolated from throat culture suggesting an emerging causative agent[...]